Marinus Pharma (MRNS) Tops Q1 EPS by 6c

Marinus Pharma (NASDAQ: MRNS) reported Q1 EPS of ($0.67), $0.06 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $10.38 million versus the consensus estimate of $5.76 million.

For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• UBS Downgrades Lai Yih Footwear Co Ltd (6890:TT) to Neutral